Cord blood ads have hypnotic effect

Share this article:
An unconventional technique led to the counter-intuitive insight behind a campaign for Cord Blood Registry (CBR).

Despite high awareness—around 90%—and acceptance of the need for cord blood banking, fewer than 5% of expectant moms bank. CBR knew it faced an action problem—not an awareness problem. “In a situation where 95% of cord blood is disposed of as medical waste, our competition is really the trash can,” said Dave Zitlow, SVP corporate communications at CBR.

The company thought cost was the most likely culprit, but that rationale didn't quite make sense, since the bank's primary target was Range Rover-driving “Yoga moms.” CBR's agency, Draftfcb, brought in an addition specialist to get under their skin. He put his subjects in a light state of hypnosis and asked them to draw what they were feeling when they decided not to bank.
“With unbelievable consistency, they kept drawing a circle around their heart connecting to the child, rather than the umbilical cord,” said Mike Rutstein, EVP director of consumer healthcare at Draftfcb.

The women, they concluded, identified love, and not the cord, as the life-giver, and could not conceive of sickness while giving life. So the campaign, in Webisodes, in-office materials and print ads running in women's and pregnancy mags, eschewed a disease focus in favor of tales of heroism, telling the stories of moms who saved lives—of their children or others through donated cord blood. In the print ads, they wore capes. “We flipped this from being about sickness and disease to being about hope and heroism,” said Rutstein.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...